R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
about
Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment optionAdvances in Primary Central Nervous System Lymphoma.Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma.Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease.Long-term remission of subcutaneous panniculitis-like T-cell lymphoma with central nervous system involvement: A case reportThe role of whole brain radiation in primary CNS lymphoma.Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapyIII. Current concepts in primary central nervous lymphoma.Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy.Primary intraventricular central nervous system lymphoma in an immunocompetent patient.High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom.The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma.How we diagnose and treat vitreoretinal lymphoma.High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review.The Challenge of Primary Central Nervous System Lymphoma.Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians.Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma.Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma.Advances in the treatment of newly diagnosed primary central nervous system lymphomas.Primary Diffuse Large B-Cell Lymphoma of Central Nervous System: Is Still Surgery an Unorthodox Treatment?A focus on pharmacotherapy for primary central nervous system lymphoma.Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: Analysis of 89 cases.Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL).Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.The Elderly Left Behind - Changes in Survival Trends of Primary Central Nervous System Lymphoma Over The Past Four Decades.Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.Diagnosis and management of primary central nervous system lymphoma.Role of radiation therapy in primary central nervous system lymphoma : KROG 14-20 Collaborative Study of Brain and Lymphoma Committee.Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study.Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05).Primary CNS Lymphoma.Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioned Autologous Stem Cell Transplantation.Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.[Primary CNS lymphoma. Progress in the diagnostics and therapy].Application value of CT and MRI in diagnosis of primary brain lymphoma.Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patients.
P2860
Q28079951-7FEF1554-DACB-48DC-95B6-7D726D8FD810Q31007237-20F1F8DC-B355-4425-9953-52850121108BQ33426914-CBC53AE4-6F5F-48B2-A7B8-AA09B283B715Q33759799-6F954AB9-F66F-49D9-8938-8269A266D373Q37002791-E2EE3222-8806-4B15-ACF1-9B1BA6E293E1Q37141915-EDD40A66-2C37-46D2-A19F-ECB25B82AE48Q37295494-56F83345-CC5A-4EEA-8D6C-0F95681C64D8Q38523967-42AAAC0C-A88E-427C-AF1A-49DA6BA8753CQ38617762-E56345BB-EB0C-4699-A31F-1366A75C77B2Q38672812-E8C7D468-9C7C-417D-BC2E-9041EDFC0787Q38743903-F1B3F8B6-3D21-41E3-A75D-720728E704DEQ38784265-8FFB2E8F-F3DE-4926-BA2A-9F406659EDAAQ38822438-3AA1A3A3-39C3-4C28-8D77-C6D1FFD30B30Q38859813-92B8AE37-A898-42D3-975D-AE5AD83490A6Q39005626-949CF875-A062-4847-B754-78BD3536EE72Q39020652-A65B4FF6-AACB-4B46-82E3-B930316B4210Q39535615-BAD95365-8C2A-4475-B4CB-965F77608426Q40071391-8DC42A0B-6C37-47C9-92A4-17BBA13734D5Q40330547-F9DC1FFE-2DD9-4098-AED2-81EBC7C6286BQ40551437-E596D865-3FAE-426F-B472-57C6C5738D17Q40831533-BA05370E-01C6-44B0-9768-9DDA015A982AQ41593361-4E89D636-C8EF-4611-BD24-03D63C192FE4Q42377771-4DCF7537-FE3F-4C75-80C0-9605FE363AFEQ42741492-F2AB70D1-6753-4D53-8377-127B3969A43FQ44251785-6389A2A8-A557-4A54-9BBD-A1B3E9E95801Q44813152-DB50B3FD-B3BC-4046-9007-5CF10B22DF51Q45047846-4AAC6915-8A69-4A74-B99D-8B1515308E3AQ47907052-EA1E3F77-3AED-4D44-8465-8005208E947DQ48016610-CAE0A018-291B-4170-81DD-6638805D6813Q48031561-1AE137EC-38AF-4B27-B6DD-1935B69EC816Q48095976-A33B45BF-B9AE-4D26-A201-54F65817C068Q48100638-A76BFC83-7821-4D2C-A89C-B3BA9E964B38Q48246102-3F73A3A5-1D7A-421A-B165-86A16ADA1634Q49330513-C251C299-3864-4744-8EAF-08A7BDEEEA15Q51841565-D80A484B-C3F8-4416-A5C4-FCBA4F7AB9CAQ52572831-A47A16DE-C301-40C2-90D1-F436931223BEQ52687205-D15E53E2-4A73-46A3-BBAD-5EBBA416D5F4Q52866187-7C4B2457-46F9-441C-8B90-C9D5DB70576EQ55332020-98FB2166-0F23-4586-A4B3-0A3C700FE564Q55402302-31064E3E-6FEC-4522-8392-6533DB9B1A0F
P2860
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
R-MPV followed by high-dose ch ...... iagnosed primary CNS lymphoma.
@ast
R-MPV followed by high-dose ch ...... iagnosed primary CNS lymphoma.
@en
type
label
R-MPV followed by high-dose ch ...... iagnosed primary CNS lymphoma.
@ast
R-MPV followed by high-dose ch ...... iagnosed primary CNS lymphoma.
@en
prefLabel
R-MPV followed by high-dose ch ...... iagnosed primary CNS lymphoma.
@ast
R-MPV followed by high-dose ch ...... iagnosed primary CNS lymphoma.
@en
P2093
P2860
P50
P1433
P1476
R-MPV followed by high-dose ch ...... iagnosed primary CNS lymphoma.
@en
P2093
Craig H Moskowitz
Craig S Sauter
Denise D Correa
Elena Pentsova
Geraldine Faivre
Katherine S Panageas
Lauren E Abrey
Raymond E Baser
P2860
P304
P356
10.1182/BLOOD-2014-10-604561
P407
P50
P577
2015-01-07T00:00:00Z